Literature DB >> 27917098

Update on Tofacitinib for Inflammatory Bowel Disease.

Brian Feagan1.   

Abstract

Entities:  

Year:  2016        PMID： 27917098      PMCID： PMC5114518     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Update on Janus kinase antagonists in inflammatory bowel disease.

Authors:  Brigid S Boland; William J Sandborn; John T Chang
Journal:  Gastroenterol Clin North Am       Date:  2014-06-24       Impact factor: 3.806

2.  Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

Authors:  William J Sandborn; Subrata Ghosh; Julian Panes; Ivana Vranic; Chinyu Su; Samantha Rousell; Wojciech Niezychowski
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

3.  A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease.

Authors:  William J Sandborn; Subrata Ghosh; Julian Panes; Ivana Vranic; Wenjin Wang; Wojciech Niezychowski
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-27       Impact factor: 11.382

Review 4.  JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines.

Authors:  Silvio Danese; Matthew Grisham; Jennifer Hodge; Jean-Baptiste Telliez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-25       Impact factor: 4.052

5.  Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.

Authors:  Julián Panés; Chinyu Su; Andrew G Bushmakin; Joseph C Cappelleri; Carla Mamolo; Paul Healey
Journal:  BMC Gastroenterol       Date:  2015-02-05       Impact factor: 3.067
  5 in total
  2 in total

Review 1.  Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease.

Authors:  Friederike Cordes; Dirk Foell; John Nik Ding; Georg Varga; Dominik Bettenworth
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

2.  The effect of a fennel seed extract on the STAT signaling and intestinal barrier function.

Authors:  Barun Das; John Rabalais; Philip Kozan; Tina Lu; Nassim Durali; Kevin Okamoto; Matthew D McGeough; Beom Jae Lee; Kim E Barrett; Ronald Marchelletta; Mamata Sivagnanam
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.